• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Livongo shares gain as first earnings print tops expectations

Livongo shares gain as first earnings print tops expectations

September 5, 2019 By Brad Perriello

Livongo logo - updatedLivongo (NSDQ:LVGO) shares gained in pre-market trading today after the digital health company posted second-quarter results that beat the consensus forecast on Wall Street, in its first earnings print since its public flotation in July.

Mountain View, Calif.-based Livongo said losses widened 129.3% to -$14.3 million, or 76¢ per share, on sales growth of 155.8% to $40.9 million for the three months ended June 30, compared with Q2 2018.

Adjusted to exclude one-time items, losses per share were -46¢, 2¢ ahead of The Street, where analysts were looking for revenues of $39.7 million.

“Our impressive second-quarter results reflect the growing appeal of our applied health signals platform,” CEO Zane Burke said in prepared remarks. “Livongo delivers a novel, consumer-first experience that our members don’t just like, but love. This leads to clinical outcomes for our members at scale, lower costs for our clients, and a compelling return on investment.”

Livongo said it expects to report adjusted earnings before interest, taxes, debt & amortization of -$41 million to -$39 million on sales of $159 million to $162 million this year. Third-quarter adjusted EBITDA are pegged at -$13 million to -$12 million on sales of $$42 million to $43 million, the company said.

“We are pleased with our second-quarter performance,” added CFO Lee Shapiro. “Our rapid growth in sales, which includes impressive acceptance of our hypertension offering, along with our per-participant-per-month subscription model and improving margins gives us strong confidence in our future.”

Livongo shares, which closed up 2.2% at $30.89 apiece yesterday, recovered from an early -1.2% slip to $30.51 this morning and were up 1.8% at $21.45 each in pre-market trading.

In July Livongo raised $355 million with its initial public offering after a last-minute upsizing.

Filed Under: Digital Health, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Livongo

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy